Search by Drug Name or NDC
NDC 55150-0179-99 Ampicillin and Sulbactam 2; 1 g/1; g/1 Details
Ampicillin and Sulbactam 2; 1 g/1; g/1
Ampicillin and Sulbactam is a INTRAVENOUS INJECTION, POWDER, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Eugia US LLC. The primary component is AMPICILLIN SODIUM; SULBACTAM SODIUM.
MedlinePlus Drug Summary
The combination of ampicillin and sulbactam injection is used to treat certain infections caused by bacteria, including infections of the skin, female reproductive organs, and abdomen (stomach area). Ampicillin is in a class of medications called penicillin-like antibiotics. It works by stopping the growth of bacteria. Sulbactam is in a class of medications called beta-lactamase inhibitors. It works by preventing bacteria from destroying ampicillin. Antibiotics such as ampicillin and sulbactam injection will not work for colds, flu, or other viral infections. Using antibiotics when they are not needed increases your risk of getting an infection later that resists antibiotic treatment.
Related Packages: 55150-0179-99Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Ampicillin and Sulbactam Injection
Product Information
NDC | 55150-0179 |
---|---|
Product ID | 55150-179_7c6af46b-5730-405f-afd3-06345c59dc32 |
Associated GPIs | |
GCN Sequence Number | n/a |
GCN Sequence Number Description | n/a |
HIC3 | n/a |
HIC3 Description | n/a |
GCN | n/a |
HICL Sequence Number | n/a |
HICL Sequence Number Description | n/a |
Brand/Generic | n/a |
Proprietary Name | Ampicillin and Sulbactam |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Ampicillin Sodium and Sulbactam Sodium |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | INJECTION, POWDER, FOR SOLUTION |
Route | INTRAVENOUS |
Active Ingredient Strength | 2; 1 |
Active Ingredient Units | g/1; g/1 |
Substance Name | AMPICILLIN SODIUM; SULBACTAM SODIUM |
Labeler Name | Eugia US LLC |
Pharmaceutical Class | Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA090340 |
Listing Certified Through | 2024-12-31 |
Package
NDC 55150-0179-99 (55150017999)
NDC Package Code | 55150-179-99 |
---|---|
Billing NDC | 55150017999 |
Package | 10 BOTTLE in 1 BOX (55150-179-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
Marketing Start Date | 2012-09-13 |
NDC Exclude Flag | N |
Pricing Information | N/A |